| Literature DB >> 31646772 |
Chul Kim1, Jidong Sung2, Jong Hwa Lee3, Won Seok Kim4,5, Goo Joo Lee6, Sungju Jee7, Il Young Jung7, Ueon Woo Rah8, Byung Ok Kim9, Kyoung Hyo Choi10, Bum Sun Kwon11, Seung Don Yoo12, Heui Je Bang13, Hyung Ik Shin14, Yong Wook Kim15, Heeyoune Jung16, Eung Ju Kim17, Jung Hwan Lee18, In Hyun Jung9, Jae Seung Jung19, Jong Young Lee20, Jae Young Han21, Eun Young Han22, Yu Hui Won23, Woosik Han24, Sora Baek25, Kyung Lim Joa26, Sook Joung Lee27, Ae Ryoung Kim28, So Young Lee22, Jihee Kim29, Hee Eun Choi30, Byeong Ju Lee31, Soon Kim32.
Abstract
Though clinical practice guidelines (CPGs) for cardiac rehabilitation (CR) are an effective and widely used treatment method worldwide, they are as yet not widely accepted in Korea. Given that cardiovascular (CV) disease is the second leading cause of death in Korea, it is urgent that CR programs be developed. In 2008, the Government of Korea implemented CR programs at 11 university hospitals as part of its Regional Cardio-Cerebrovascular Center Project, and 3 additional medical facilities will be added in 2019. In addition, owing to the promotion of CR nationwide and the introduction of CR insurance benefits, 40 medical institutions nationwide have begun CR programs even as a growing number of medical institutions are preparing to offer CR. The purpose of this research was to develop evidence-based CPGs to support CR implementation in Korea. This study is based on an analysis of CPGs elsewhere in the world, an extensive literature search, a systematic analysis of multiple randomized control trials, and a CPG management, development, and assessment committee comprised of thirty-three authors-primarily rehabilitation specialists, cardiologists, and thoracic surgeons in 21 university hospitals and 2 general hospitals. Twelve consultants, primarily rehabilitation, sports medicine, and preventive medicine specialists, CPG experts, nurses, physical therapists, clinical nutritionists, and library and information experts participated in the research and development of these CPGs. After the draft guidelines were developed, 3 rounds of public hearings were held with staff members from relevant academic societies and stakeholders, after which the guidelines were further reviewed and modified. CR involves a more cost-effective use of healthcare resources relative to that of general treatments, and the exercise component of CR lowers CV mortality and readmission rates, regardless of the type of coronary heart disease and type and setting of CR. Individualized CR programs should be considered together with various factors, including differences in heart function and lifestyle, and doing so will boost participation and adherence with the CR program, ultimately meeting the final goals of the program, namely reducing the recurrence of myocardial infarction and mortality rates.Entities:
Keywords: Acute coronary syndrome; Cardiac rehabilitation; Clinical practice guideline; Mortality; Secondary prevention
Year: 2019 PMID: 31646772 PMCID: PMC6813162 DOI: 10.4070/kcj.2019.0194
Source DB: PubMed Journal: Korean Circ J ISSN: 1738-5520 Impact factor: 3.243
Appraisal of foreign clinical practice guidelines for cardiac rehabilitation with AGREE II
| Guideline | Reviewer | Rigor of development | Rigor percentage | Total score for each domain | Overall appraisal | Result |
|---|---|---|---|---|---|---|
| Scotland (SIGN 2107) | 1 | 50 | 83% | 130 | 6 | Selected |
| 2 | 46 | 125 | 6 | |||
| England (NICE 2013) | 3 | 50 | 89% | 121 | 6 | Partial selection |
| 4 | 56 | 135 | 6 | |||
| United States (AHA 2011) | 5 | 37 | 67% | 90 | 5 | Partial selection |
| 6 | 30 | 89 | 4 | |||
| Canada (CACR 2009) | 7 | 20 | 44% | 71 | 3 | Partial reference |
| 8 | 38 | 99 | 4 | |||
| Japan (JCS 2012) | 7 | 26 | 34% | 70 | 3 | Partial reference |
| 8 | 23 | 75 | 4 |
AGREE II = appraisal guidelines for research and evaluation II; AHA = American Heart Association; CACR = Canadian Association of Cardiac Rehabilitation; JCS = Japanese Circulation Society; NICE = National Institute for Health and Care Excellence; SIGN = Scottish Intercollegiate Guidelines Network.
Key questions for clinical practice guidelines for cardiac rehabilitation
| Question | Description |
|---|---|
| KQ1 | Must cardiac rehabilitation be included in the treatment of ACS? |
| KQ2 | Does cardiac rehabilitation influence the outcome of patients with CVD? |
| KQ3 | Does cardiac rehabilitation improve the quality of life of patients with CVD? |
| KQ4 | When should cardiac rehabilitation be begun? (timing of cardiac rehabilitation) |
| KQ5 | How should cardiac rehabilitation programs be structured? |
| KQ6 | Can cardiac rehabilitation programs lower health management costs for patients with ACS? |
| KQ7 | Are individualized cardiac rehabilitation programs more effective than the existing fixed cardiac rehabilitation program? |
| KQ8 | Should psychological interventions concerning anxiety, depression, and stress be included in the cardiac rehabilitation program? |
| KQ9 | Is a cardiopulmonary exercise test necessary for cardiac rehabilitation? |
| KQ10 | Is a submaximal exercise test, such as a 6-minute walk test, useful for cardiac rehabilitation? |
| KQ11 | What are the effective measures for promoting participation in cardiac rehabilitation? |
| KQ12 | What are the effective measures for increasing physical activity compliance rates? |
| KQ13 | When should patients begin cardiac rehabilitation following coronary artery bypass grafting? |
| KQ14 | Should aerobic exercises be included in the cardiac rehabilitation program? |
| KQ15 | Should resistance (muscle training) exercises be included in the cardiac rehabilitation program? |
| KQ16 | How can the safety of cardiac rehabilitation exercises be enhanced? |
| KQ17 | Can a home-based cardiac rehabilitation program replace a hospital-based cardiac rehabilitation program? |
| KQ18 | Should cardiac rehabilitation programs be recommended to elderly patients? |
| KQ19 | Is patient education a necessary part of cardiac rehabilitation? |
| KQ20 | What contents should be included in patient education? |
| KQ21 | What interventions are needed to improve patients' adherence to taking their medications? |
| KQ22 | What is an effective intervention for patients who need to stop smoking? |
| KQ23 | What diet therapies are recommended for patients undergoing cardiac rehabilitation? |
| KQ24 | Should a specific food supplement be recommended? |
| KQ25 | Would an ICT-based modality be helpful in maintaining the effects of education in the long-term? |
ACS = acute coronary syndrome; CVD = cardiovascular disease; ICT = information and communication technology.
Levels of evidence5)
| Levels | Evidence |
|---|---|
| 1++ | High-quality meta-analyses, systematic reviews of randomized control trials, or randomized control trials with a very low RoB |
| 1+ | Well-conducted meta-analyses, systematic reviews, or randomized control trials with a low RoB |
| 1− | Meta-analyses, systematic reviews, or randomized control trials with a high RoB |
| 2++ | High-quality systematic reviews of case-control or cohort studies |
| High-quality case-control or cohort studies with a very low-risk of confounding or bias and a high probability that the relationship is causal | |
| 2+ | Well-conducted case-control or cohort studies with a low-risk of confounding or bias and a moderate probability that the relationship is causal |
| 2− | Case-control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal |
| 3 | Non-analytic studies, e.g., case reports, case series |
| 4 | Expert opinion |
ROB = risk of bias.
Recommendations5)
| Some recommendations can be made with more certainty than others. The wording used in the recommendations in this guideline denotes the certainty with which the recommendation is made (the ‘strength’ of the recommendation). | |
| The ‘strength’ of a recommendation takes into account the quality (level) of the evidence. Although higher-quality evidence is more likely to be associated with strong recommendations than lower-quality evidence, a particular level of quality does not automatically lead to a particular strength of recommendation. | |
| Other factors that are taken into account when forming recommendations include: relevance to the National Health Service in Scotland; applicability of published evidence to the target population; consistency of the body of evidence, and the balance of benefits and harms of the options. | |
| R | For “strong” recommendations on interventions that “should” be used, the guideline development group is confident that, for the vast majority of people, the intervention (or interventions) will do more good than harm. For ‘strong’ recommendations on interventions that ‘should not’ be used, the guideline development group is confident that, for the vast majority of people, the intervention (or interventions) will do more harm than good. |
| R | For “conditional” recommendations on interventions that should be “considered,” the guideline development group is confident that the intervention will do more good than harm for most patients. The choice of intervention is therefore more likely to vary depending on a person's values and preferences, and so the healthcare professional should spend more time discussing the options with the patient. |
| Good-practice points | |
| √ | Recommended best practice based on the clinical experience of the guideline development group. |
Key recommendations of CR
| 1. Introduction of CR | |
| • CR programs must be included in the treatment of ACS (SOR: strong/LOE: 1++) | |
| • CR exercise should be initiated as early as possible following acute phase treatment (SOR: strong/LOE: 1−) | |
| 2. Assessments of CR | |
| • Cardiopulmonary exercise testing should be performed to assess patients' cardiopulmonary exercise functions, prescribe exercise, and predict outcomes (SOR: strong/LOE: 2++) | |
| • Interventions to increase self-efficacy and awareness of the need for CR are needed to increase CR participation (SOR: strong/LOE: 1++) | |
| • Systematized automatic referrals and liaison systems should be considered to increase CR referral rates. (SOR: GPP/LOE: 2−) | |
| 3. Exercise therapy for CR | |
| • CR should be initiated early after surgery, as an inpatient program for patients who undergo CABG (SOR: strong/LOE: 1++) | |
| • Risk assessment and appropriate monitoring based on the risk assessment results should be performed to ensure patient safety during CR exercise programs (SOR: strong/LOE: 2++) | |
| • CR programs should also be administered to patients aged 65 years and older (SOR: strong/LOE: 1++) | |
| 4. Education for secondary prevention | |
| • CR programs should include patient education (SOR: strong/LOE: 1++) | |
| • Smoking cessation interventions should be provided for patients who smoke, and continuous interventions of more than 4 weeks should be considered (SOR: strong/LOE: 1++) | |
| • ICT-based modalities should be considered to maintain the effects of education (SOR: conditional/LOE: 1−) | |
ACS = acute coronary syndrome; CABG = coronary artery bypass grafting; CR = cardiac rehabilitation; GPP = good-practice point; ICT = information and communication technology; LOE = levels of evidence; SOR = strength of recommendations.
Absolute and relative contraindications to resistance training
| Absolute | |
| Unstable coronary heart disease | |
| Decompensated heart failure | |
| Uncontrolled arrhythmias | |
| Severe pulmonary hypertension (mean pulmonary arterial pressure>55 mmHg) | |
| Severe and symptomatic aortic stenosis | |
| Acute myocarditis, endocarditis, or pericarditis | |
| Uncontrolled hypertension (>180/110 mmHg) | |
| Aortic dissection | |
| Marfan syndrome | |
| High-intensity RT (80–100% of 1-RM) in patients with active proliferative retinopathy or moderate or worse non-proliferative diabetic retinopathy | |
| Relative (should consult a physician before participation) | |
| Major risk factors for coronary heart disease | |
| Diabetes at any age | |
| Uncontrolled hypertension (>160/100 mmHg) | |
| Low functional capacity (<4 metabolic equivalents of task) | |
| Musculoskeletal limitations | |
| Individuals with implanted pacemakers or defibrillators | |
Education contents for CR in SIGN 20175)
| Throughout entire CR program | |
| - Education about the effects of cardiovascular events/coronary artery disease, such as myocardial infarction, on psychological/emotional state | |
| - To promote secondary prevention, explain the purpose and need for the prescribed medications and encourage patients to adhere to prescription- guide patients to additionally obtain appropriate information | |
| Before discharge | |
| - Provide information about disease and other precautions: name of diagnosis, how to respond to chest pain (including nitroglycerin sublingual tablet or spray), recommendations about appropriate daily activities and driving, return to work | |
| - Provide additional relevant educational materials | |
| - Inform about upcoming treatments, interventions, and appointments | |
| - Purpose and need for CR program. How to contact the CR team | |
| - (For smokers) Importance of smoking cessation | |
| When assessing CR | |
| - Additional education according to patient needs: physical activity, exercise, smoking cessation, weight management, nutritional education, psychological/emotional response to disease | |
| - Needs for and benefits of maintaining exercise habits in the long-term; can perform exercise safely and effectively at the appropriate intensity | |
| - Ways to contact the CR team when in need of advice or support | |
CR = cardiac rehabilitation; SIGN = Scottish Intercollegiate Guidelines Network.
Diet program for cardiac rehabilitation program
| Item | Contents | Notes |
|---|---|---|
| Diet pattern | Diversify food groups within the appropriate total energy consumption to maintain a healthy weight, including whole grains, vegetables, fruits, fish (blue-backed fish), poultry, beans, and nuts. | Major foreign guidelines prioritize a guideline for overall diet patterns. Korean guidelines do not provide instructions about diet patterns, but it would be desirable to include one, owing to the nature of the diet culture. However, considering Koreans' food culture, we did not mention dairies (low fat). |
| Fat | Limit total fat intake to 30% of total energy intake. Limit saturated fat intake to 7% of total energy intake. Replace saturated fats with MUFA and PUFA, and limit omega-6 PUFA to 10% of total energy intake. Limit trans-fat intake to 1% of total energy intake. | Generally, accept the recommendations of the KSLA guideline (However, to increase the emphasis on MUFA, we revised the guideline to separately mention MUFA and PUFA). |
| Cholesterol | Limit daily cholesterol intake to 300 mg. | Recently, multiple foreign guidelines tend to delete a guideline for cholesterol. However, we included this, as some foreign guidelines still limit daily cholesterol intake to 200–300 mg, and the Korean nutrient standard and KSLA guideline limits daily cholesterol intake to 300 mg. |
| Salt | Limit daily salt intake to 5 g (daily sodium intake to 2 g) | Daily salt intake ranges from 4–6 g in foreign guidelines. To remain consistent with the Korean nutrient standard, we set daily salt intake to 5 g. |
| Fibers | Eat enough whole grains and vegetables to keep daily fiber intake above 25 g. | European guidelines set daily fiber intake to 30–45 g, but Canadian, American, and Korean guidelines set the cutoff to 25 g. |
| Sugars | Limit added sugar (sugars added during cooking or processing) intake to 10% of total energy intake | Most foreign major guidelines include a phrase about limiting sugar-sweetened beverages in their diet pattern guideline. Because sugar intake is on the rise recently, it is valid to include sugar intake in the guideline. As with the added sugar standard in the Korean nutrient standard, added sugars are limited to 10% of total energy intake. |
| Alcohol | It is desirable to avoid drinking. | In unavoidable cases, alcohol should be limited to 2 shots a day for men (20 mg) and 1 shot a day for women (10 mg). Alcohol intake should be minimized to control blood pressure and body weight. |
KSLA = Korean Society of Lipid and Atherosclerosis; MUFA = monounsaturated fatty acid; PUFA = polyunsaturated fatty acid.